Skip to main content
logo
PRISM BioLab Co.,LTD (TYO:206A)
Japan flag Japan · Delayed Price · Currency is JPY
170.00
+2.00 (1.19%)
Aug 27, 2026, 1:36 PM JST

PRISM BioLab Co.,LTD Financials Overview

Millions JPY. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Revenue
737.27677.33305.62112.93554
Revenue Growth
84.85%121.63%170.64%-79.62%-
Gross Profit
375.62269.76160.5480.31535
Operating Income
-850.75-774.45-782.39-496.8767
Net Income
-875.43-833.7-1,050-526.9172
Earnings Per Share
-23.73-22.82-33.53-19.092.63
EPS Growth
-----

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023
Period EndingSep '25 Sep '24 Sep '23
Japan
11069.6368.04
United States of America
523.5219.211.78
Switzerland
43.8316.7912.06
Total
677.33305.62112.93

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Cash (Debt)
2,3312,9164,3921,1341,687
Net Cash Growth
-29.43%-33.62%287.32%-32.78%-
Net Cash Per Share
63.1879.81140.3041.0861.68
Cash & Investments
2,3312,9164,3921,1341,687

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Operating Cash Flow
--1,468150.14-513.81-
Capital Expenditures
--64.7-205.79-34.59-
Free Cash Flow
--1,533-55.64-548.4-
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22
Gross Margin
50.95%39.83%52.53%71.11%96.57%
Operating Margin
-115.39%-114.34%-256.00%-439.99%12.09%
Pretax Margin
-118.41%-122.73%-342.98%-465.53%13.18%
Profit Margin
-118.74%-123.09%-343.41%-466.60%13.00%
FCF Margin
--226.34%-18.21%-485.63%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22
PS Ratio
8.429.1048.24--